Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-107007
Filing Date
2024-09-17
Accepted
2024-09-17 06:26:43
Documents
5
Effectiveness Date
2024-09-17

Document Format Files

Seq Description Document Type Size
1 S-8 tnya_09-2024_s-8.htm S-8 158969
2 EX-5.1 tnya-ex5_1.htm EX-5.1 15074
3 EX-23.1 tnya-ex23_1.htm EX-23.1 4373
4 EX-FILING FEES tnya-exfiling_fees.htm EX-FILING FEES 23003
5 GRAPHIC img208693244_0.jpg GRAPHIC 3633
  Complete submission text file 0000950170-24-107007.txt   207657
Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Filer) CIK: 0001858848 (see all company filings)

IRS No.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-282161 | Film No.: 241302520
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)